STOCK-BASED COMPENSATION- (Tables)

9 Months Ended

Dec. 31, 2023

Equity [Abstract]

Schedule of Stock-based Compensation Activity, by Award Type

The Company's stock-based compensation activity for the nine months ended December 31, 2023 and 2022, by award type, was (dollars in thousands):

	For the nine months ended
	December 31,
	2023		2022
Stock options	$	405	$	776
Restricted stock units, time-vesting	36,706		65,214
Restricted stock units, performance based	4,876		5,398
Data Plus Math ("DPM") acquisition consideration holdback	—		2,031
Acuity performance plan	165		673
DataFleets acquisition consideration holdback	2,267		4,532
Employee stock purchase plan	1,167		1,527
Directors stock-based compensation	938		991
Total non-cash stock-based compensation included in the condensed consolidated statements of operations	46,524		81,142
Less expense related to liability-based equity awards	(2,431)		(7,237)
Total non-cash stock-based compensation included in the condensed consolidated statements of equity	$	44,093	$	73,905

Schedule of Effect of Stock-based Compensation Expense on Income, by Financial Statement Line Item

The effect of stock-based compensation expense on income, by financial statement line item, was (dollars in thousands):

	For the nine months ended
	December 31,
	2023		2022
Cost of revenue	$	2,075	$	3,664
Research and development	17,330		34,670
Sales and marketing	12,611		17,871
General and administrative	14,508		24,937
Total non-cash stock-based compensation included in the condensed consolidated statements of operations	$	46,524	$	81,142

Schedule of Share-based Compensation Arrangement by Share Based Payment Award, Future Expense

The following table provides the expected future expense for all of the Company's outstanding equity awards at December 31, 2023, by award type. The amount for fiscal 2024 represents the remaining three months ending March 31, 2024. All other periods represent fiscal years ending March 31 (dollars in thousands).

	For the years ending March 31,
	2024		2025		2026		2027		Total
Stock options	$	81	$	90	$	—	$	—	$	171
Restricted stock units	21,871		78,291		30,440		4,716		135,318
Employee stock purchase plan	431		431		—		—		862
Expected future expense	$	22,383	$	78,812	$	30,440	$	4,716	$	136,351

Schedule of Option Activity

Stock option activity for the nine months ended December 31, 2023 was:  

				Weighted-average
		Weighted-average		remaining	Aggregate
	Number of	exercise price		contractual term	Intrinsic value
	shares	per share		(in years)	(in thousands)
Outstanding at March 31, 2023	524,911	$	18.39
Exercised	(151,706)	$	19.37		$	860
Forfeited or canceled	(2,410)	$	5.21
Outstanding at December 31, 2023	370,795	$	18.08	1.2	$	7,342
Exercisable at December 31, 2023	368,662	$	18.18	1.2	$	7,264

Schedule of Stock Options Outstanding and Exercisable

A summary of stock options outstanding and exercisable as of December 31, 2023 was:

					Options outstanding				Options exercisable
Range of						Weighted-average	Weighted-average			Weighted-average
exercise price					Options	remaining	exercise price		Options	exercise price
per share					outstanding	contractual life	per share		exercisable	per share
$	—	—	$	9.99	23,542	5.0 years	$	0.95	21,409	$	0.93
$	10.00	—	$	19.99	182,603	1.4 years	$	17.49	182,603	$	17.49
$	20.00	—	$	24.99	164,650	0.5 years	$	21.18	164,650	$	21.18
					370,795	1.2 years	$	18.08	368,662	$	18.18

Schedule of Time-vesting Restricted Stock Unit Activity

RSU activity for the nine months ended December 31, 2023 was:

		Weighted-average
		fair value per		Weighted-average
	Number	share at grant		remaining contractual
	of shares	date		term (in years)
Outstanding at March 31, 2023	4,009,759	$	32.57	2.20
Granted	1,730,545	$	26.95
Vested	(890,679)	$	32.03
Forfeited or canceled	(378,510)	$	33.66
Outstanding at December 31, 2023	4,471,115	$	30.41	1.70

Schedule of Non-vested Performance-based Restricted Stock Units Activity

PSU activity for the nine months ended December 31, 2023 was:

		Weighted-average
		fair value per		Weighted-average
	Number	share at grant		remaining contractual
	of shares	date		term (in years)
Outstanding at March 31, 2023	709,589	$	34.97	1.01
Granted	666,496	$	31.58
Vested	(55,968)	$	47.11
Forfeited or canceled	(214,760)	$	40.19
Outstanding at December 31, 2023	1,105,357	$	31.29	1.84